Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Does the therapy manual or the therapist matter most in treatment of obsessive-compulsive disorder? A randomized controlled trial of exposure with response or ritual prevention in 118 patients.

van Oppen P, van Balkom AJ, Smit JH, Schuurmans J, van Dyck R, Emmelkamp PM.

J Clin Psychiatry. 2010 Sep;71(9):1158-67. doi: 10.4088/JCP.08m04990blu. Epub 2010 Mar 23.

PMID:
20361906
2.

A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials.

Tolin DF, Hannan S, Maltby N, Diefenbach GJ, Worhunsky P, Brady RE.

Behav Ther. 2007 Jun;38(2):179-91. Epub 2007 Jan 23.

PMID:
17499084
3.

Psychological treatment of obsessive-compulsive disorder: a meta-analysis.

Rosa-Alcázar AI, Sánchez-Meca J, Gómez-Conesa A, Marín-Martínez F.

Clin Psychol Rev. 2008 Dec;28(8):1310-25. doi: 10.1016/j.cpr.2008.07.001. Epub 2008 Jul 4.

PMID:
18701199
4.

Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control.

Greist JH, Marks IM, Baer L, Kobak KA, Wenzel KW, Hirsch MJ, Mantle JM, Clary CM.

J Clin Psychiatry. 2002 Feb;63(2):138-45.

PMID:
11874215
5.

Home self-assessment and self-treatment of obsessive-compulsive disorder using a manual and a computer-conducted telephone interview: replication of a UK-US study.

Bachofen M, Nakagawa A, Marks IM, Park JM, Greist JH, Baer L, Wenzel KW, Parkin JR, Dottl SL.

J Clin Psychiatry. 1999 Aug;60(8):545-9.

PMID:
10485637
6.

Cognitive-behavioral therapy as an adjunct to serotonin reuptake inhibitors in obsessive-compulsive disorder: an open trial.

Simpson HB, Gorfinkle KS, Liebowitz MR.

J Clin Psychiatry. 1999 Sep;60(9):584-90.

PMID:
10520976
7.

Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up.

van Oppen P, van Balkom AJ, de Haan E, van Dyck R.

J Clin Psychiatry. 2005 Nov;66(11):1415-22.

PMID:
16420079
8.

Cognitive versus behavior therapy: processes of change in the treatment of obsessive-compulsive disorder.

Anholt GE, Kempe P, de Haan E, van Oppen P, Cath DC, Smit JH, van Balkom AJ.

Psychother Psychosom. 2008;77(1):38-42. Epub 2007 Dec 14.

PMID:
18087206
9.

D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.

Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK.

Int Clin Psychopharmacol. 2007 Jul;22(4):230-7. Erratum in: Int Clin Psychopharmacol. 2007 Sep;22(5):312.

PMID:
17519647
10.

Manual-Driven group cognitive-behavioral therapy for adolescents with obsessive-compulsive disorder: a pilot study.

Thienemann M, Martin J, Cregger B, Thompson HB, Dyer-Friedman J.

J Am Acad Child Adolesc Psychiatry. 2001 Nov;40(11):1254-60.

PMID:
11699798
11.

Controlled trial of exposure and response prevention in obsessive-compulsive disorder.

Lindsay M, Crino R, Andrews G.

Br J Psychiatry. 1997 Aug;171:135-9.

PMID:
9337948
12.

The efficacy of teaching psychology students exposure and response prevention for obsessive-compulsive disorder.

Solem S, Hansen B, Vogel PA, Ottesen Kennair LE.

Scand J Psychol. 2009 Jun;50(3):245-50. doi: 10.1111/j.1467-9450.2008.00703.x. Epub 2008 Dec 29.

PMID:
19170968
13.

Stepped care versus standard cognitive-behavioral therapy for obsessive-compulsive disorder: a preliminary study of efficacy and costs.

Tolin DF, Diefenbach GJ, Gilliam CM.

Depress Anxiety. 2011 Apr;28(4):314-23. doi: 10.1002/da.20804. Epub 2011 Mar 4.

14.

Predicting therapy outcome in patients with early and late obsessive-compulsive disorder (EOCD and LOCD).

Langner J, Laws M, Röper G, Zaudig M, Hauke W, Piesbergen C.

Behav Cogn Psychother. 2009 Oct;37(5):485-96. doi: 10.1017/S1352465809990294.

PMID:
19796435
15.

Six-month follow-up of a randomized controlled trial augmenting serotonin reuptake inhibitor treatment with exposure and ritual prevention for obsessive-compulsive disorder.

Foa EB, Simpson HB, Liebowitz MR, Powers MB, Rosenfield D, Cahill SP, Campeas R, Franklin M, Hahn CG, Hembree EA, Huppert JD, Schmidt AB, Vermes D, Williams MT.

J Clin Psychiatry. 2013 May;74(5):464-9. doi: 10.4088/JCP.12m08017.

16.

Behavioural group therapy for obsessive-compulsive disorder in Norway. An open community-based trial.

Håland AT, Vogel PA, Lie B, Launes G, Pripp AH, Himle JA.

Behav Res Ther. 2010 Jun;48(6):547-54. doi: 10.1016/j.brat.2010.03.005. Epub 2010 Mar 12.

PMID:
20359692
18.

Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale.

Storch EA, Lewin AB, De Nadai AS, Murphy TK.

J Am Acad Child Adolesc Psychiatry. 2010 Jul;49(7):708-17. doi: 10.1016/j.jaac.2010.04.005. Epub 2010 Jun 2.

PMID:
20610140
19.

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.

Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL.

Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409. doi: 10.1176/appi.ajp.2007.07050776. Epub 2008 Feb 1.

PMID:
18245177
20.

Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples.

Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB.

J Consult Clin Psychol. 2000 Aug;68(4):594-602.

PMID:
10965635

Supplemental Content

Support Center